Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Current Opinion in Oncology
|
November 15, 2011
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2
Alexandra Borodovsky, Meghan J Seltzer, Gregory J Riggins
Expert Opinion on Drug Discovery
|
October 20, 2018
Targeting adenosine A<sub>2A</sub> receptor antagonism for treatment of cancer
Miles Congreve, Giles A Brown, Alexandra Borodovsky, et al.
Neuro-Oncology
|
September 6, 2018
Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide
Alex Shimura Yamashita, Marina da Costa Rosa, Alexandra Borodovsky, et al.
Analytical Biochemistry
|
November 9, 2018
Development of a quantification method for adenosine in tumors by LC-MS/MS with dansyl chloride derivatization
Kelly J Goodwin, Eric Gangl, Ujjal Sarkar, et al.
Molecular Cancer Therapeutics
|
November 8, 2014
Repurposing the antihelmintic mebendazole as a hedgehog inhibitor
Andrew R Larsen, Ren-Yuan Bai, Jon H Chung, et al.
Journal of Neuro-Oncology
|
December 5, 2014
A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres
Alexandra Borodovsky, Alan K Meeker, Ewen F Kirkness, et al.
Oncotarget
|
October 1, 2013
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine
Sevin Turcan, Armida W M Fabius, Alexandra Borodovsky, et al.
Frontiers in Immunology
|
March 19, 2021
Evaluation of Combination Strategies for the A<sub>2A</sub>R Inhibitor AZD4635 Across Tumor Microenvironment Conditions <i>via</i> a Systems Pharmacology Model
Veronika Voronova, Kirill Peskov, Yuri Kosinsky, et al.
Oncotarget
|
October 1, 2013
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
Alexandra Borodovsky, Vafi Salmasi, Sevin Turcan, et al.
Molecular Cancer
|
December 8, 2017
Generation of stable PDX derived cell lines using conditional reprogramming
Alexandra Borodovsky, Travis J McQuiston, Daniel Stetson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Current Opinion in Oncology
|
November 15, 2011
Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2
Alexandra Borodovsky, Meghan J Seltzer, Gregory J Riggins
Expert Opinion on Drug Discovery
|
October 20, 2018
Targeting adenosine A<sub>2A</sub> receptor antagonism for treatment of cancer
Miles Congreve, Giles A Brown, Alexandra Borodovsky, et al.
Neuro-Oncology
|
September 6, 2018
Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide
Alex Shimura Yamashita, Marina da Costa Rosa, Alexandra Borodovsky, et al.
Analytical Biochemistry
|
November 9, 2018
Development of a quantification method for adenosine in tumors by LC-MS/MS with dansyl chloride derivatization
Kelly J Goodwin, Eric Gangl, Ujjal Sarkar, et al.
Molecular Cancer Therapeutics
|
November 8, 2014
Repurposing the antihelmintic mebendazole as a hedgehog inhibitor
Andrew R Larsen, Ren-Yuan Bai, Jon H Chung, et al.
Journal of Neuro-Oncology
|
December 5, 2014
A model of a patient-derived IDH1 mutant anaplastic astrocytoma with alternative lengthening of telomeres
Alexandra Borodovsky, Alan K Meeker, Ewen F Kirkness, et al.
Oncotarget
|
October 1, 2013
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine
Sevin Turcan, Armida W M Fabius, Alexandra Borodovsky, et al.
Frontiers in Immunology
|
March 19, 2021
Evaluation of Combination Strategies for the A<sub>2A</sub>R Inhibitor AZD4635 Across Tumor Microenvironment Conditions <i>via</i> a Systems Pharmacology Model
Veronika Voronova, Kirill Peskov, Yuri Kosinsky, et al.
Oncotarget
|
October 1, 2013
5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft
Alexandra Borodovsky, Vafi Salmasi, Sevin Turcan, et al.
Molecular Cancer
|
December 8, 2017
Generation of stable PDX derived cell lines using conditional reprogramming
Alexandra Borodovsky, Travis J McQuiston, Daniel Stetson, et al.
Page
of 2